Table 4.

Descriptions of parameters.

Parameter	Description	Value	References
$b_i$	Infection probability of a person in age group $i$ per contact	Table 5	Estimated
$m_{ij}$	Number of contacts made by a person in age group $j$ with people in age group $i$	Figure S1	[36]
${\varphi }_i$	Vaccination allocation for age group $i$	vary	Estimated
$v$	Daily vaccination doses	88,283	[8,9]
$VP$	Vaccination period	180	[45]
$VC$	Total vaccine coverage	0.7	[45]
$\tau$	Vaccine efficacy	0.88	[10,11,12,13,14,45]
${\theta }_P$	Relative infectiousness of pre-symptomatic infectious	0.51	[27]
${\theta }_A$	Relative infectiousness of asymptomatic infectious	0.51	[27]
${\theta }_I$	Relative infectiousness of symptomatically infectious	1	[27]
$1/{\alpha }_E$	Latent period $\left(day\right)$	3	[46]
$1/{\alpha }_P$	Pre-symptomatic period $\left(day\right)$	3.2	[46]
$\rho$	Probability of having symptoms	0.84	[27]
$1/q$	Mean duration of case confirmation $\left(day\right)$	3	[36]
$1/{\gamma }^A$	Recovery period of asymptomatic cases $\left(day\right)$	3.5	[27]
$1/{\gamma }_i^M$	Recovery period of mild symptom cases for group $i\left(day\right)$	* 15.3, 14.9, 16.3, 15.9, 15.5, 15.8, 16.5, 18.2	[32]
$1/{\gamma }_i^S$	Recovery period of severe symptom cases for group $i\left(day\right)$	* 15.3, 14.9, 16.3, 15.9, 15.5, 15.8, 16.5, 18.2	[32]
${\kappa }_i$	Probability of having severe symptoms	0.26	[47]
${\mu }_i$	Death rate of individuals in $H^S$ in age group $i$	* 0, 0, 0, 0, 0.001, 0.002, 0.009, 0.0832	[32]

* For cells with an asterisk (*), values from left to right at the top (bottom) are for age groups: 0–9, 10–19, 20–29, and 30–39 (40–49, 50–59, 60–69, and 70+).